ECP therapy for patients with stable angina waiting for CABG

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of External Counterpulsation (ECP) therapy in patients with stable angina pectoris who are on a waiting list for coronary artery bypass grafting (CABG). The study aims to determine if adding ECP therapy to optimal medical treatment can relieve symptoms and improve quality of life during the waiting period. Participants will be randomized into two groups: one receiving ECP therapy and the other receiving standard medical therapy alone. The efficacy will be assessed through echocardiographic measurements, treadmill tests, and clinical outcomes before and after the intervention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \>= 18 years old
* Diagnosed with stable angina pectoris
* Anatomic vessel disease (VD) lesion with 2VD/3VD
* Indicated for CABG and in waiting list of CABG procedure; or refuse for CABG and choose medical therapy only; or patients who are decided by the responsible doctor for medical treatment alone because of the high risks of CABG surgery.
* Not planned to urgent CABG
* Minimum optimal medical therapy within 2 weeks
* Able and willing to sign informed consent and comply with study procedures
* The patient lives in Bandung City and its neighborhood
* Retired patient; or not actively working during working hours; or willing to take the time to participate in research.

Exclusion Criteria:

* Congestive Heart Failure
* Chronic heart failure with Functional Class NYHA III - IV
* LVEF \<35%
* Unprotected left main stenosis \>50%
* Blood pressure \>180/110mmHg
* Acute coronary syndrome
* Acute Heart Failure
* Severe aorta regurgitation
* Malignant arrhythmia
* Atrial fibrillation
* Premature ventricular complex
* Peripheral occlusive artery disease
* Phlebitis
* Deep vein thrombosis
* Hemorrhagic diathesis
* Severe chronic kidney disease
* Aortic aneurysm
* Abdominal aneurysm
* Osteoarthritis
* Low back pain
* Pregnancy
* Registered as other clinical study participant

Where it's running

• Dr. Hasan Sadikin General Hospital
  Bandung, West Java, Indonesia Recruiting

Study contacts

• Principal investigator: Mohammad R Akbar, MD, FIHA. — Universitas Padjadjaran
• Study coordinator: Mohammad R Akbar, MD, FIHA.
• Email: m.r.akbar@unpad.ac.id
• Phone: +6281221040265

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions

  This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.

  Recruiting at 3 sites Teleflex · Washington D.C., District of Columbia and 2 other locations · NCT07258290

• Targeted medical therapy for angina with non-obstructive coronary arteries

  This study is testing if a new targeted medication can help people with angina and non-obstructive coronary arteries feel better and improve their quality of life.

  Recruiting Phase 2/3 Stanford University · Palo Alto, California · NCT06424834

• Using AI to predict acute coronary syndrome from white blood cell data

  This study is testing if artificial intelligence can predict acute coronary syndrome by looking at white blood cell data in adults, comparing it to standard blood tests.

  Recruiting RobotDreams GmbH · Graz, Styria / Steiermark · NCT06384846

• Registry to track management and outcomes of patients with complex coronary artery disease

  This study is tracking how well different treatments for complex coronary artery disease work in patients who have had procedures like stents or bypass surgery.

  Recruiting Luzerner Kantonsspital · Lucerne, Canton of Lucerne · NCT06075602

• Registry to evaluate outcomes of coronary artery disease patients treated with specific balloon catheters

  This study looks at how well certain drug-coated balloons work for patients with coronary artery disease who have had a specific heart procedure, to see how they help with recovery and overall health.

  Recruiting Luzerner Kantonsspital · Lucerne, Canton of Lucerne · NCT04988685

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.